sodium esomeprazole

Poland

Drugs containing this active substance

  • ESOMEPRAZOLE ACCORD

    The medicine is used for the short-term treatment of gastroesophageal reflux disease (manifesting as pain, inflammation, and heartburn) and gastric ulcers caused by the use of anti-inflammatory drugs (NSAIDs). It also helps to prevent the recurrence of bleeding following endoscopic treatment of gastric or duodenal ulcers.

    Form: powder for preparation of solution for injection and infusion

    Active substance Dosage
    sodium esomeprazole 40 mg

    ATC: A02BC05

    Manufacturer: Accompagny Healthcare Polska Ltd.

  • The medicine is used for the short-term treatment of conditions where oral administration is not possible. In adults, it helps in the treatment of gastroesophageal reflux disease, gastric ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs), and prevents the recurrence of bleeding after ulcer treatment. In children and adolescents (1–18 years), it is used in the treatment of gastroesophageal reflux disease.

    Form: powder for preparation of solution for injection / infusion

    Active substance Dosage
    sodium esomeprazole 42.5 mg

    ATC: A02BC05

    Manufacturer: Laboratorios Normon, S.A.

  • The medicine is used in adults for the short-term treatment of reflux symptoms, such as heartburn (chest pain radiating upwards to the throat) and acid regurgitation (acidic taste in the mouth).

    Form: capsules, hard, intestinal

    Active substance Dosage
    sodium esomeprazole 21.28 mg

    ATC: A02BC05

    Manufacturer: Lek Pharmaceuticals d.d. TOWA Pharmaceutical Europe S.L.

  • The medicine is used to treat gastroesophageal reflux disease (causing pain, inflammation, and heartburn) and gastric ulcers caused by the use of non-steroidal anti-inflammatory drugs. It may also be used to prevent recurrent bleeding after endoscopic treatment of ulcers and to prevent the formation of ulcers in people taking anti-inflammatory drugs.

    Form: powder for preparation of solution for injection / infusion

    Active substance Dosage
    sodium esomeprazole 42.5 mg

    ATC: A02BC05

    Manufacturer: Valdepharm

  • The medicine is used to treat gastroesophageal reflux disease (manifesting, among other things, as heartburn and pain), gastric or intestinal ulcer disease (also caused by Helicobacter pylori bacteria or anti-inflammatory drugs), as well as in cases of excessive gastric acid secretion caused by a pancreatic tumor.

    Form: capsules, hard, intestinal

    Active substance Dosage
    sodium esomeprazole 42.56 mg

    ATC: A02BC05

    Manufacturer: TOWA Pharmaceuticals Europe, S.L.

  • The medicine is used for short-term treatment of diseases when the patient cannot take medication orally. In adults, it helps in the treatment of gastroesophageal reflux disease, gastric ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs), and prevents recurrence of bleeding after endoscopy. In children and adolescents (1–18 years), it is used for the treatment of gastroesophageal reflux disease.

    Form: powder for preparation of solution for injection and infusion

    Active substance Dosage
    esomeprazole 40 mg
    sodium esomeprazole 42.5 mg

    ATC: A02BC05

    Manufacturer: Tillomed Malta Limited